Parameters influencing the stealthiness of colloidal drug delivery systems

Biomaterials

Volumn 27, Issue 24, 2006, Pages 4356-4373

  Vonarbourg, Arnaud ^a   Passirani, Catherine ^a   Saulnier, Patrick ^a   Benoit, Jean Pierre ^a  

^a UNIVERSITÉ D'ANGERS   (France)

Author keywords

Complement; Liposome; Macrophage; Nanoparticle; Polyethylene oxide; Protein adsorption

Indexed keywords

BLOOD; CELLS; NANOSTRUCTURED MATERIALS; PHYSIOLOGY; POLYMERIC MEMBRANES; TISSUE;

COMPLEMENT; LIPOSOME; MACROPHAGE; NANOPARTICLE; POLYETHYLENE OXIDE; PROTEIN ADSORPTION;

CONTROLLED DRUG DELIVERY;

LIPID; LIPOPOLYSACCHARIDE; NANOPARTICLE; OPSONIN; POLY(ETHYL 2 CYANOACRYLATE); POLY(METHYL 2 CYANOACRYLATE); POLY(METHYL METHACRYLATE); POLYARGININE; POLYGLACTIN; POLYMER; POLYSTYRENE; UNCLASSIFIED DRUG;

CELL INTERACTION; CELL MEMBRANE; CELL SURFACE; CIRCULATION; COLLOID; CONFORMATION; DENSITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; ELECTRICITY; HYDROPHILICITY; IMMUNE SYSTEM; MACROPHAGE; MOLECULAR WEIGHT; MONONUCLEAR PHAGOCYTE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; TARGET ORGAN;

ANIMALS; COLLOIDS; COMPLEMENT SYSTEM PROTEINS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MACROPHAGES; NANOSTRUCTURES;

EID: 33646384586     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.03.039     Document Type: Review

References (181)

1. Puisieux F., Barratt G., Couarraze G., Couvreur P., Devissaguet J.P., Dubernet C., et al. Polymeric micro and nanoparticles as drug carriers. In: Dimitriu S. (Ed). Polymeric biomaterials (1994), Marcel Dekker, Inc., New York 749-794
2. Stolnik S., Illum L., and Davis S. Long-circulating microparticulate drug carriers. Adv Drug Deliv Rev 16 (1995) 195-214
3. Allen T.M., Hansen C.B., and Lopes de Menezes D.E. Pharmacokinetics of long-circulating liposomes. Adv Drug Del Rev 16 (1995) 267-284
4. Lobenberg R., and Kreuter J. Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy. AIDS Res Hum Retroviruses 12 (1996) 1709-1715
5. Gaspar R., Preat V., Opperdoes F.R., and Roland M. Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. Pharm Res 9 (1992) 782-787
6. Rihova B. Immunomodulating activities of soluble synthetic polymer-bound drugs. Adv Drug Deliv Rev 54 (2002) 653-674
7. Moghimi S.M., and Hunter A.C. Capture of stealth nanoparticles by the body's defences. Crit Rev Ther Drug Carrier Syst 18 (2001) 527-550
8. Adams D.O., and Hamilton T.A. The cell biology of macrophage activation. Annu Rev Immunol 2 (1984) 283-318
9. Demoy M., Andreux J.P., Weingarten C., Gouritin B., Guilloux V., and Couvreur P. In vitro evaluation of nanoparticles spleen capture. Life Sci 64 (1999) 1329-1337
10. Lu W., Tan Y.Z., Hu K.L., and Jiang X.G. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. Int J Pharm 295 (2005) 247-260
11. Moghimi S.M., and Bonnemain B. Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography. Adv Drug Deliv Rev 37 (1999) 295-312
12. Chen H., Langer R., and Edwards D.A. A film tension theory of phagocytosis. J Colloid Interface Sci 190 (1997) 118-133
13. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., and Walter IV P. Internal organization of the cell->13. Intracellular vesicular traffic. Molecular biology of the cell. 4th ed (2002), Garland Publishing, New York
14. Panyam J., and Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 20 (2003) 212-220
15. Tabata Y., and Ikada Y. Phagocytosis of polymer microspheres by macrophages. Adv Polym Sci 94 (1990) 107-141
16. Mosqueira V.C., Legrand P., Gulik A., Bourdon O., Gref R., Labarre D., et al. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials 22 (2001) 2967-2979
17. Bocca C., Caputo O., Cavalli R., Gabriel L., Miglietta A., and Gasco M.G. Phagocytic uptake of fluorescent stealth and no-stealth solid lipid nanoparticles. Int J Pharm 175 (1998) 185-193
18. Thiele L., Rothen-Rutishauser B., Jilek S., Wunderli-Allenspach H., Merkle H.P., and Walter E. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?. J Control Release 76 (2001) 59-71
19. Gbadamosi J.K., Hunter A.C., and Moghimi S.M. PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance. FEBS Lett 532 (2002) 338-344
20. Kaim A.H., Wischer T., O'Reilly T., Jundt G., Frohlich J., von Schulthess G.K., et al. MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats. Radiology 225 (2002) 808-814
21. Rolland A., Merdrignac G., Gouranton J., Bourel D., Le Verge R., and Genetet B. Flow cytometric quantitative evaluation of phagocytosis by human mononuclear and polymorphonuclear cells using fluorescent nanoparticles. J Immunol Methods 96 (1987) 185-193
22. Zambaux M.F., Faivre-Fiorina B., Bonneau F., Marchal S., Merlin J.L., Dellacherie E., et al. Involvement of neutrophilic granulocytes in the uptake of biodegradable non-stealth and stealth nanoparticles in guinea pig. Biomaterials 21 (2000) 975-980
23. Duval-Araujo I., Antunes R.A., Ramirez e Dolga C.H., and Simal C.J. 99mTC sulphur colloid phagocytosis by the mononuclear phagocytic system (MPS) of rats with portal hypertension. Minerva Chir 54 (1999) 403-409
24. Lacasse F.X., Filion M.C., Phillips N.C., Escher E., McMullen J.N., and Hildgen P. Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis. Pharm Res 15 (1998) 312-317
25. Mosqueira V.C., Legrand P., Gref R., Heurtault B., Appel M., and Barratt G. Interactions between a macrophage cell line (J774A1) and surface-modified poly (d,l-lactide) nanocapsules bearing poly(ethylene glycol). J Drug Target 7 (1999) 65-78
26. Papisov M.I. Theoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions. Adv Drug Deliv Rev 32 (1998) 119-138
27. Patel H.M., and Moghimi S.M. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system-the concept of tissue specificity. Adv Drug Deliv Rev 32 (1998) 45-60
28. Kiwada H., Matsuo H., and Harashima H. Identification of proteins mediating clearance of liposomes using a liver perfusion system. Adv Drug Deliv Rev 32 (1998) 61-79
29. Kamps J.A., and Scherphof G.L. Receptor versus non-receptor mediated clearance of liposomes. Adv Drug Deliv Rev 32 (1998) 81-97
30. Sparrow C.P., Parthasarathy S., and Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem 264 (1989) 2599-2604
31. Patel H.M. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit Rev Ther Drug Carrier Syst 9 (1992) 39-90
32. Liu F., and Liu D. Serum independent liposome uptake by mouse liver. Biochim Biophys Acta 1278 (1996) 5-11
33. Liu D., Hu Q., and Song Y.K. Liposome clearance from blood: different animal species have different mechanisms. Biochim Biophys Acta 1240 (1995) 277-284
34. van Furth R., van Schadewijk-Nieuwstad M., Elzenga-Claasen I., Cornelisse C., and Nibbering P. Morphological, cytochemical, functional, and proliferative characteristics of four murine macrophage-like cell lines. Cell Immunol 90 (1985) 339-357
35. Harashima H., Komatsu S., Kojima S., Yanagi C., Morioka Y., Naito M., et al. Species difference in the disposition of liposomes among mice, rats, and rabbits: allometric relationship and species dependent hepatic uptake mechanism. Pharm Res 13 (1996) 1049-1054
36. Kinoshita T. Biology of complement: the overture. Immunol Today 12 (1991) 291-295
37. Osmand A.P., Friedenson B., Gewurz H., Painter R.H., Hofmann T., and Shelton E. Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci USA 74 (1977) 739-743
38. Bristow C.L., and Boackle R.J. Evidence for the binding of human serum amyloid P component to Clq and Fab gamma. Mol Immunol 23 (1986) 1045-1052
39. Volanakis J.E., and Kaplan M.H. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q. J Immunol 113 (1974) 9-17
40. Siegel J., Osmand A.P., Wilson M.F., and Gewurz H. Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-l-lysine polymers and other polycations. J Exp Med 142 (1975) 709-721
41. Sahu A., and Lambris J.D. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 180 (2001) 35-48
42. Passirani C., Barratt G., Devissaguet J.P., and Labarre D. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. Life Sci 62 (1998) 775-785
43. Szebeni J., Muggia F.M., and Alving C.R. Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst 90 (1998) 300-306
44. Kazatchkine M.D., Hauptmann G., and Nydegger U.E. Techniques du complément (1986), Inserm, Paris p. 22-3
45. Kabat E.A., and Mayer M.M. Experimental immunochemistry (1961), Thomas, Springfield, IL, USA p. 133-56
46. Gref R., Domb A., Quellec P., Blunk T., Muller R.H., Verbavatz J.M., et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 16 (1995) 215-233
47. Dunn S.E., Brindley A., Davis S.S., Davies M.C., and Illum L. Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution. Pharm Res 11 (1994) 1016-1022
48. Peracchia M.T., Vauthier C., Passirani C., Couvreur P., and Labarre D. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. Life Sci 61 (1997) 749-761
49. Vittaz M., Bazile D., Spenlehauer G., Verrecchia T., Veillard M., Puisieux F., et al. Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. Biomaterials 17 (1996) 1575-1581
50. Cruz T., Gaspar R., Donato A., and Lopes C. Interaction between polyalkylcyanoacrylate nanoparticles and peritoneal macrophages: MTT metabolism, NBT reduction, and NO production. Pharm Res 14 (1997) 73-79
51. Muller R.H., Mader K., and Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 50 (2000) 161-177
52. Chellat F., Grandjean-Laquerriere A., Le Naour R., Fernandes J., Yahia L., Guenounou M., et al. Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles. Biomaterials 26 (2005) 961-970
53. Heurtault B, Saulnier P, Benoit JP, Proust JE, Pech B, Richard J. Nanocapsules lipidiques, procédé de préparation et utilisation comme médicament. French Patent No. 00 02688,2000.
54. Heurtault B., Saulnier P., Pech B., Proust J.E., and Benoit J.P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 19 (2002) 875-880
55. Lamprecht A., Saumet J.L., Roux J., and Benoit J.P. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm 278 (2004) 407-414
56. Bradley A.J., Devine D.V., Ansell S.M., Janzen J., and Brooks D.E. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch Biochem Biophys 357 (1998) 185-194
57. Volanakis J.E., and Narkates A.J. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J Immunol 126 (1981) 1820-1825
58. Thiel S. Mannan-binding protein, a complement activating animal lectin. Immunopharmacology 24 (1992) 91-99
59. Kuhlman M., Joiner K., and Ezekowitz R.A. The human mannose-binding protein functions as an opsonin. J Exp Med 169 (1989) 1733-1745
60. Illum L., Hunneyball I.M., and Davis S.S. The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages. Int J Pharma 29 (1986) 53-65
61. Cullis P.R., Chonn A., and Semple S.C. Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo. Adv Drug Deliv Rev 32 (1998) 3-17
62. Mold C. Effect of membrane phospholipids on activation of the alternative complement pathway. J Immunol 143 (1989) 1663-1668
63. Derksen J.T., Morselt H.W., Kalicharan D., Hulstaert C.E., and Scherphof G.L. Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro. Exp Cell Res 168 (1987) 105-115
64. Allen T.M., Austin G.A., Chonn A., Lin L., and Lee K.C. Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim Biophys Acta 1061 (1991) 56-64
65. Nilsson U.R., Storm K.E., Elwing H., and Nilsson B. Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface. Mol Immunol 30 (1993) 211-219
66. Harashima H., Huong T.M., Ishida T., Manabe Y., Matsuo H., and Kiwada H. Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats. Pharm Res 13 (1996) 1704-1709
67. Chonn A., Cullis P.R., and Devine D.V. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J Immunol 146 (1991) 4234-4241
68. Torchilin V.P., and Papisov M.I. Why do polyethylene glycol-coated liposomes circulate so long? (molecular mechanism of liposome steric protection with polyethylene glycol: role of polymer chain flexibility). J Liposome Res 4 (1994) 725-739
69. Montdargent B., Maillet F., Carreno M.P., Jozefowicz M., Kazatchkine M., and Labarre D. Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces. Biomaterials 14 (1993) 203-208
70. Chonn A., Semple S.C., and Cullis P.R. Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J Biol Chem 270 (1995) 25845-25849
71. Horkko S., Miller E., Branch D.W., Palinski W., and Witztum J.L. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). Proc Natl Acad Sci USA 94 (1997) 10356-10361
72. Moghimi S.M., and Hunter A.C. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol 18 (2000) 412-420
73. Alving C.R., and Swartz Jr. G.M. Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity. Crit Rev Immunol 10 (1991) 441-453
74. Carreno M.P., Maillet F., Labarre D., Jozefowicz M., and Kazatchkine M.D. Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum. Biomaterials 9 (1988) 514-518
75. Maillet F., and Kazatchkine M.D. Specific antibodies enhance alternative complement pathway activation by cuprophane. Nephrol Dial Transplant 6 (1991) 193-197
76. Videm V., and Mollnes T.E. Human complement activation by polygeline and dextran 70. Scand J Immunol 39 (1994) 314-320
77. Passirani C., and Benoit J.P. Complement activation by injectable colloidal drug carriers. Biomaterials for delivery and targeting of proteins and nucleic acids (2005), CRC Press, Inc., Boca Raton 187-230
78. Harashima H., Hiraiwa T., Ochi Y., and Kiwada H. Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling. J Drug Target 3 (1995) 253-261
79. Roerdink F., Wassef N.M., Richardson E.C., and Alving C.R. Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement. Biochim Biophys Acta 734 (1983) 33-39
80. Mosesson M.W., and Amrani D.L. The structure and biologic activities of plasma fibronectin. Blood 56 (1980) 145-158
81. Hautanen A., and Keski-Oja J. Affinity of myeloma IgG proteins for fibronectin. Clin Exp Immunol 53 (1983) 233-238
82. Rossi J.D., and Wallace B.A. Binding of fibronectin to phospholipid vesicles. J Biol Chem 258 (1983) 3327-3331
83. Cardarelli P.M., Blumenstock F.A., McKeown-Longo P.J., Saba T.M., Mazurkiewicz J.E., and Dias J.A. High-affinity binding of fibronectin to cultured Kupffer cells. J Leukoc Biol 48 (1990) 426-437
84. Czop J.K. Phagocytosis of particulate activators of the alternative complement pathway: effects of fibronectin. Adv Immunol 38 (1986) 361-398
85. Bradley A.J., and Devine D.V. The complement system in liposome clearance: can complement deposition be inhibited?. Adv Drug Deliv Rev 32 (1998) 19-29
86. Moghimi S.M., and Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42 (2003) 463-478
87. Yu B., Hailman E., and Wright S.D. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 99 (1997) 315-324
88. Devitt A., Moffatt O.D., Raykundalia C., Capra J.D., Simmons D.L., and Gregory C.D. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392 (1998) 505-509
89. Shibuya-Fujiwara N., Hirayama F., Ogata Y., Ikeda H., and Ikebuchi K. Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors. Life Sci 70 (2001) 291-300
90. Harmon C.M., and Abumrad N.A. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J Membr Biol 133 (1993) 43-49
91. Rigotti A., Acton S.L., and Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 270 (1995) 16221-16224
92. Serra M.V., Mannu F., Matera A., Turrini F., and Arese P. Enhanced IgG- and complement-independent phagocytosis of sulfatide-enriched human erythrocytes by human monocytes. FEBS Lett 311 (1992) 67-70
93. Huang M., Ma Z., Khor E., and Lim L.Y. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res 19 (2002) 1488-1494
94. Lee K.D., Nir S., and Papahadjopoulos D. Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. Biochemistry 32 (1993) 889-899
95. Nussbaum O., Rott R., and Loyter A. Fusion of influenza virus particles with liposomes: requirement for cholesterol and virus receptors to allow fusion with and lysis of neutral but not of negatively charged liposomes. J Gen Virol 73 Pt 11 (1992) 2831-2837
96. Juliano R.L., and Stamp D. Biochem. Biophys Res Commun 63 (1975) 651-685
97. Senior J.H. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst 3 (1987) 123-193
98. Harashima H., Sakata K., Funato K., and Kiwada H. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm Res 11 (1994) 402-406
99. Devine D.V., Wong K., Serrano K., Chonn A., and Cullis P.R. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta 1191 (1994) 43-51
100. Rudt S., and Muller R.H. In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. III. Uptake of differently sized surface-modified particles, and its correlation to particle properties and in vivo distribution. Eur J Pharma Sci 1 (1993) 31-39
101. Li J., Caldwell K., and Rapoport N. Surface properties of pluronic-coated polymeric colloids. Langmuir 10 (1994) 4475-4482
102. Vonarbourg A, Passirani C, Saulnier P, Benoit JP. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res A 2006, in press.
103. Smith C.A., Vogel C.W., and Muller-Eberhard H.J. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement. J Biol Chem 257 (1982) 9879-9882
104. Schwendener R.A., Lagocki P.A., and Rahman Y.E. The effects of charge and size on the interaction of unilamellar liposomes with macrophages. Biochim Biophys Acta 772 (1984) 93-101
105. Pratten M.K., and Lloyd J.B. Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim Biophys Acta 881 (1986) 307-313
106. Harashima H., Yamane C., Kume Y., and Kiwada H. Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency. J Pharmacokinet Biopharm 21 (1993) 299-308
107. Vincent F., de la Salle H., Bohbot A., Bergerat J.P., Hauptmann G., and Oberling F. Synthesis and regulation of complement components by human monocytes/macrophages and by acute monocytic leukemia. DNA Cell Biol 12 (1993) 415-423
108. Spanjer H.H., van Galen M., Roerdink F.H., Regts J., and Scherphof G.L. Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition. Biochim Biophys Acta 863 (1986) 224-230
109. Gabizon A., and Papahadjopoulos D. The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim Biophys Acta 1103 (1992) 94-100
110. Tabata Y., and Ikada Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 9 (1988) 356-362
111. Luck M., Paulke B.R., Schroder W., Blunk T., and Muller R.H. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. J Biomed Mater Res 39 (1998) 478-485
112. Claesson P.M., Blomberg E., Froberg J.C., Nylander T., and Arnebrant T. Protein interactions at solid interface. Adv Colloid Interface Sci 57 (1995) 161-227
113. Jeon S.I., Lee J.H., Andrade J.D., and De Gennes P.G. Protein-surface interactions in the presence of polyethylene oxide I. Simplified theory. J Colloid Interface Sci 142 (1991) 149-158
114. Jeon S.I., Lee J.H., Andrade J.D., and De Gennes P.G. Protein-surface interactions in the presence of polyethylene oxide. II: effect of protein size. J Colloid Interface Sci 142 (1991) 159-166
115. Nagaoka S., Mori Y., Takiuchi H., Yokota K., Tanzawa H., and Nishiumi S. In: Shalaby S.W., Hoffman A.S., Ratner B.D., and Horbett T.E. (Eds). Polymers as biomaterials (1985), Plenum Press, New York 331
116. Nagaoka S., Mori Y., Tanzawa H., and Nishiumi S. Interaction between blood components and hydrogels with poly(oxyethylene) chains. In: Holfman A.S., Ratner D.B., and Horbett T.E. (Eds). Polymers as biomaterials (1984), Plenum Press, New York 361-374
117. Israelachvili J.N. Intermolecular and surface forces (1985), Academic Press, London
118. Vermette P., and Meagher L. Interactions of phospholipid- and poly(ethylene glycol)-modified surfaces with biological systems: relation to physico-chemical properties and mechanisms. Colloids Surf B: Biointerfaces 28 (2003) 153-198
119. Ahl P.L., Bhatia S.K., Meers P., Roberts P., Stevens R., Dause R., et al. Enhancement of the in vivo circulation lifetime of l-alpha-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization. Biochim Biophys Acta 1329 (1997) 370-382
120. Chonn A., Semple S.C., and Cullis P.R. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J Biol Chem 267 (1992) 18759-18765
121. Black C.D., and Gregoriadis G. Interaction of liposomes with blood plasma proteins. Biochem Soc Trans 4 (1976) 253-256
122. Molnar J., McLain S., Allen C., Laga H., Gara A., and Gelder F. The role of an alpha2-macroglobulin of rat serum in the phagocytosis of colloidal particles. Biochim Biophys Acta 493 (1977) 37-54
123. Juliano R.L., and Lin G. The binding of human plasma proteins to cholesterol containing liposomes. Six BTaH. Liposomes and Immunobiology (1980), Elsevier, New York 49-66
124. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18 (2000) 301-313
125. Moghimi S.M., Muir I.S., Illum L., Davis S.S., and Kolb-Bachofen V. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta-Mol Cell Res 1179 (1993) 157-165
126. Dijkstra J., van Galen M., and Scherphof G. Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles. Biochim Biophys Acta 813 (1985) 287-297
127. Hsu M.J., and Juliano R.L. Interactions of liposomes with the reticuloendothelial system. II: nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim Biophys Acta 720 (1982) 411-419
128. Roser M., Fischer D., and Kissel T. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 46 (1998) 255-263
129. Wilhelm C., Billotey C., Roger J., Pons J.N., Bacri J.C., and Gazeau F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24 (2003) 1001-1011
130. Lee K.-D., Hong K., and Papahadjopoulos D. Recognition of liposomes by cells: In vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. Biochim Biophys Acta-Biomembran 1103 (1992) 185-197
131. Vetvicka V., and Fornusek L. Polymer microbeads in immunology. Biomaterials 8 (1987) 341-345
132. Allen T.M. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. AdV Drug Del Rev 13 (1994) 285-309
133. Macritchie F. The adsorption of proteins at the solid/liquid interface. J Colloid Interface Sci 38 (1972) 484-488
134. Golander C.G., Herron J.N., Lim K., Claesson P., Stenius P., and Andrade J.D. Properties of immobilized PEG films and interaction with proteins, experiments and modelling. In: Harris J.M.E. (Ed). Poly(ethylene glycol) chemistry: biotechnical and biomedical applications (1992), Plenum Press, New York 221-245
135. Allen T.M. A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles. Biochim Biophys Acta 640 (1981) 385-397
136. van Oss C.J. Phagocytosis as a surface phenomenon. Annu Rev Microbiol 32 (1978) 19-39
137. Van Oss C.J., Gillman C.F., and Neuman A.W. Phagocytic engulfment and cell adhesiveness as cellular surface phenomena (1975), Marcel Dekker, Inc., New York 160p
138. Moghimi S.M. Liposome recognition by resident and newly recruited murine liver macrophages. J Liposome Res 12 (2002) 67-70
139. Cevc G., and Richardsen H. Lipid vesicles and membrane fusion. Adv Drug Deliv Rev 38 (1999) 207-232
140. Burgess S.W., Massenburg D., Yates J., and Lentz B.R. Poly(ethylene glycol)-induced lipid mixing but not fusion between synthetic phosphatidylcholine large unilamellar vesicles. Biochemistry 30 (1991) 4193-4200
141. Coleman D.L., Gregonis D.E., and Andrade J.D. Blood-materials interactions: the minimum interfacial free energy and the optimum polar/apolar ratio hypotheses. J Biomed Mater Res 16 (1982) 381-398
142. Lee J.H., Kopeckova P., Kopecek J., and Andrade J.D. Surface properties of copolymers of alkyl methacrylates with methoxy (polyethylene oxide) methacrylates and their application as protein-resistant coatings. Biomaterials 11 (1990) 455-464
143. Lemarchand C., Gref R., and Couvreur P. Polysaccharide-decorated nanoparticles. Eur J Pharma Biopharm 58 (2004) 327-341
144. Calvo P., Alonso M.J., Vila-Jato J.L., and Robinson J.R. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol 48 (1996) 1147-1152
145. Jordan A., Scholz R., Wust P., Schirra H., Schiestel T., Schmidt H., et al. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J Magn Magn Mater 194 (1999) 185-196
146. Bazile D., Prud'homme C., Bassoullet M.T., Marlard M., Spenlehauer G., Veillard M., et al. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 84 (1995) 493-498
147. Torchilin V., and Trubetskoy V. Which polymers can make nanoparticulate drug carriers long-circulating?. Adv Drug Deliv Rev 16 (1995) 141-155
148. Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., and Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta 1128 (1992) 44-49
149. Torchilin V.P. Polymer-coated long-circulating microparticulate pharmaceuticals. J Microencapsul 15 (1998) 1-19
150. Illum L., Jacobsen L.O., Muller R.H., Mak E., and Davis S.S. Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials 8 (1987) 113-117
151. Osterberg E., Bergstrom K., Holmberg K., Schuman T.P., Riggs J.A., Burns N.L., et al. Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG. J Biomed Mater Res 29 (1995) 741-747
152. Heurtault B., Saulnier P., Pech B., Benoit J.P., and Proust J.E. Interfacial stability of lipid nanocapsules. Colloids Surf B: Biointerfaces 30 (2003) 225-235
153. Antonsen K.P., and Hoffman A.S. Water structure of PEG solutions by diffrential calorimetry measurements. In: Harris J.M.E. (Ed). Poly(ethylene glycol) chemistry: biotechnical and biomedical applications (1992), Plenum Press, New York 15-27
154. Szleifer I. Polymers and proteins: interactions at interfaces. Current Opin Solid State Mater Sci 2 (1997) 337-344
155. Pavey K.D., and Olliff C.J. SPR analysis of the total reduction of protein adsorption to surfaces coated with mixtures of long- and short-chain polyethylene oxide block copolymers. Biomaterials 20 (1999) 885-890
156. Moghimi S.M., Pavey K.D., and Hunter A.C. Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908. FEBS Lett 547 (2003) 177-182
157. Huang M., Khor E., and Lim L.Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 21 (2004) 344-353
158. Watrous-Peltier N., Uhl J., Steel V., Brophy L., and Merisko-Liversidge E. Direct suppression of phagocytosis by amphipathic polymeric surfactants. Pharm Res 9 (1992) 1177-1183
159. Amiji M.M. Synthesis of anionic poly(ethylene glycol) derivative for chitosan surface modification in blood-contacting applications. Carbohydrate Polym 32 (1997) 193-199
160. Zambaux M.F., Bonneaux F., Gref R., Dellacherie E., and Vigneron C. MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties. J Biomed Mater Res 44 (1999) 109-115
161. Gombotz W.R., Wang G.H., Horbett T.A., and Hoffman A.S. Protein adsorption to poly(ethylene oxide) surfaces. J Biomed Mater Res 25 (1991) 1547-1562
162. Benecky M.J., Kolvenbach C.G., Wine R.W., DiOrio J.P., and Mosesson M.W. Human plasma fibronectin structure probed by steady-state fluorescence polarization: evidence for a rigid oblate structure. Biochemistry 29 (1990) 3082-3091
163. Lim K, Herron JN. Molecular simulation of protein PEG interaction. In: Harris JME, editor. Poly(ethylene glycol) chemistry: biotechnical and biomedical applications. New York: Plenum Press; 1992. p. 29-55.
164. Kingshott P., Thissen H., and Griesser H.J. Effects of cloud-point grafting, chain length, and density of PEG layers on competitive adsorption of ocular proteins. Biomaterials 23 (2002) 2043-2056
165. Stolnik S., Daudali B., Arien A., Whetstone J., Heald C.R., Garnett M.C., et al. The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. Biochim Biophys Acta 1514 (2001) 261-279
166. Bergstrom K., Osterberg E., Holmberg K., Hoffman A.S., Schuman T.P., Kozlowski A., et al. Effects of branching and molecular weight of surface-bound poly(ethylene oxide) on protein rejection. J Biomater Sci Polym Ed 6 (1994) 123-132
167. Kenworthy A.K., Simon S.A., and McIntosh T.J. Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol). Biophys J 68 (1995) 1903-1920
168. Yang Z., Galloway J.A., and Yu H. Protein interactions with poly(ethylene glycol) self-assembled monolayers on glass substrates: diffusion and adsorption. Langmuir 15 (1999) 8405-8411
169. Razatos A., Ong Y., Boulay F., Elbert D., Hubbell J.A., Sharma M.M., et al. Force measurements between bacteria and poly(ethylene glycol)-coated surfaces. Langmuir 16 (2000) 9155-9158
170. Papisov M.I., Martin C., Poss K., Weissleder R., and Brady T.J. Amplification of steric effects in cooperative systems. Twenty-second international symposium on controlled release of bioactive materials (1995) 442-443
171. Johnstone S.A., Masin D., Mayer L., and Bally M.B. Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages. Biochim Biophys Acta 1513 (2001) 25-37
172. Torchilin V.P., Omelyanenko V.G., Papisov M.I., Bogdanov Jr. A.A., Trubetskoy V.S., Herron J.N., et al. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1195 (1994) 11-20
173. Labarre D., Laurent A., Lautier A., Bouhni S., Kerbellec L., Lewest J.M., et al. Complement activation by substituted polyacrylamide hydrogels for embolisation and implantation. Biomaterials 23 (2002) 2319-2327
174. Lemarchand C., Gref R., Petri B., Passirani C., Müller R., Costantini D., et al. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials (2006)
175. Woodle M.C., and Lasic D.D. Sterically stabilized liposomes. Biochim Biophys Acta 1113 (1992) 171-199
176. Chaffee S., Mary A., Stiehm E.R., Girault D., Fischer A., and Hershfield M.S. IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency. J Clin Invest 89 (1992) 1643-1651
177. Wilkinson B.J., Peterson P.K., and Quie P.G. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect Immun 23 (1979) 502-508
178. Kurata M., and Tsunashima Y. Viscosity-molecular weight relationships and unperturbed dimensions of linear chain molecules. In: Brandup Ja.H.E.H. (Ed). Polymer handbook (1989), Wiley, New York VII/1
179. Thiele L., Diederichs J.E., Reszka R., Merkle H.P., and Walter E. Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells. Biomaterials 24 (2003) 1409-1418
180. Allemann E., Gravel P., Leroux J.C., Balant L., and Gurny R. Kinetics of blood component adsorption on poly(d,l-lactic acid) nanoparticles: evidence of complement C3 component involvement. J Biomed Mater Res 37 (1997) 229-234
181. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47 (2001) 65-81